A man experiencing episodes of worsening facial swelling

For patients with the rare immunological syndrome acquired angioedema associated with C1 inhibitor deficiency, replacement therapy with plasma-derived C1 INH concentrate is standard treatment. For those who develop resistance to replacement therapy, another drug has been shown to be successful in managing acute episodes.